FDA Statement on the Signing of the Right to Try Act

May 30, 2018 – U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, released the following statement today: For patients with serious or immediately life-threatening diseases, the FDA remains committed to enhancing access to promising investigational medicines for those unable to access products through clinical trials. This is the mission of our expanded-access program. The agency is dedicated to these purposes, and it has been for more than 3 … (leggi tutto)